ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

por Liu, Shuochen, Fan, Shilong, Wang, Yirui, Chen, Ruixiang, Wang, Ziyi, Zhang, Yaodong, Jiang, Wangjie, Chen, Yananlan, Xu, Xiao, Yu, Yue, Li, Changxian, Li, Xiangcheng
Publicado 2023

ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal

por Zhou, Tao, Zhang, Yaodong, Chen, Yananlan, Shan, Jijun, Wang, Jifei, Wang, Yirui, Chang, Jiang, Jiang, Wangjie, Chen, Ruixiang, Wang, Ziyi, Shi, Xiaoli, Yu, Yue, Li, Changxian, Li, Xiangcheng
Publicado 2022

Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation

por Chen, Yananlan, Xu, Xiao, Wang, Yirui, Zhang, Yaodong, Zhou, Tao, Jiang, Wangjie, Wang, Ziyi, Chang, Jiang, Liu, Shuochen, Chen, Ruixiang, Shan, Jijun, Wang, Jifei, Wang, Yuming, Li, Changxian, Li, Xiangcheng
Publicado 2023

NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1

por Shan, Jijun, Jiang, Wangjie, Chang, Jiang, Zhou, Tao, Chen, Yananlan, Zhang, Yaodong, Wang, Jifei, Wang, Yuming, Wang, Yirui, Xu, Xiao, Liu, Shuochen, Shi, Xiaoli, Fan, Shilong, Chen, Ruixiang, Li, Changxian, Li, Xiangcheng
Publicado 2023